Patanjali Foods (PATANJALI) Q1 24/25 earnings summary

Executive summary

• Q1 FY25 began with strong profitability, as EBITDA doubled year-over-year to INR 435 crore and PAT nearly tripled to INR 262.91 crore, driven by stable edible oil prices and steady Food & FMCG performance.

• Board approved the acquisition of Patanjali Ayurved's Home and Personal Care (HPC) business for INR 1,100 crore, pending regulatory and shareholder approval.

• Edible oil segment showed signs of recovery and strong profitability despite market volatility.

• Food and FMCG segment maintained its revenue contribution, supported by new product launches and increased marketing efforts.

• Ongoing expansion in oil palm cultivation and rural outreach initiatives.

Financial highlights

• Revenue from operations for Q1 FY25 was INR 7,173 crore, down from INR 7,767.10 crore YoY.

• EBITDA rose to INR 435.08 crore, up 105.2% YoY; EBITDA margin improved to 6.07% from 2.73%.

• PAT nearly tripled to INR 262.91 crore; PAT margin increased to 3.67%.

• Food & FMCG segment revenue was INR 1,953.55 crore, contributing 26.77% of total revenue.

• Edible Oils segment sales were INR 5,330.33 crore, with branded oils making up 79.54% of segment sales.

Outlook and guidance

• Acquisition of the HPC business is expected to strengthen the FMCG portfolio and drive future revenue and EBITDA growth.

• Management expects rural demand improvement, steady urban consumption, and continued expansion in oil palm cultivation.

• Recovery in high-margin Indian specialty foods anticipated in the next quarter; normalized revenue run rates projected for consumer staples and specialty foods.

• Nutraceuticals targeted to reach INR 100–125 crore revenue in FY25 at 25% margin, with 20–25% annual growth expected.

• Focus on marketing, consumer activation, and product innovation.